tailieunhanh - Protein Kinase A-induced tamoxifen resistance is mediated by anchoring protein AKAP13

Estrogen Receptor alpha (ERα)-positive breast cancer patients receive endocrine therapy, often in the form of tamoxifen. However, resistance to tamoxifen is frequently observed. A signalling cascade that leads to tamoxifen resistance is dictated by activation of the Protein Kinase A (PKA) pathway, which leads to phosphorylation of ERα on Serine 305 and receptor activation, following tamoxifen binding. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN